ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 357885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 357885; 2) Community: the network communities that were significantly associated with the response to NSC 357885; 3) Molecule: the relationships between components within communities and NSC 357885; 4) MDR: the compounds that were significantly associated with the NSC 357885.

NSC Compound Enrichment Correlation
NSC 697859 Null 0.00550789647802199 -0.190534
NSC 673841 1H-Dipyrazolo[1,5-a:4',3'-e]pyrimidine-3,4,7-triamine, 6-[(4-bromophenyl)azo]- 0.00578566967432527 0.054373509
NSC 609699 Topotecan hydrochloride 0.00645628049634952 0.67685629
NSC 610458 Camptothecin Derivative 0.00645628049634952 0.60947155
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.00645628049634952 0.17406589
NSC 631391 7H-Pyrido[4,3-c]carbazole-6-methanol,methylcarbamate (ester) (9CI) 0.00645628049634952 0.28384533
NSC 639174 Camptothecin Derivative 0.00645628049634952 0.62347322
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.00645628049634952 0.69656747
NSC 676775 Olean-12-en-28-oic acid, 3-.beta.-[2-O-(.beta.-D-glucopyranosyl)- .beta.-D-glucopyranosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-.beta.-D-xylopyranosyl]- 6-deo 0.00645628049634952 -0.156768
NSC 681639 Camptothecin Derivative 0.00645628049634952 0.64750734
Total:45  Current:6    [First] [Prev] [Next] [Last]